type 2 diabetes
Conditions
Interventions
U300 glargine:Use U300 glargine to regulate blood glucose. When FBG and 2hBG meet the standard, cross use another basic insulin with the same dose
U100 glargine:Use U100 glargine to regulate blood glucose. When FBG and 2hBG meet the standard, cross use another basic insulin with the same dose
Sponsors
The Second Affiliated Hospital, Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: The patient was diagnosed with T2DM, and the newly diagnosed patient's glycosylated hemoglobin (HbA1C) = 9.0% or fasting blood glucose (FPG) = 11.1 mmol/L, or the patient with HbA1C = 7.0% after three months of pharmacologoc therapy, 18-75 years old, with no abnormal liver function and glomerular filtration rate (eGFR)>45, agreed to use insulin treatment.
Exclusion criteria
Exclusion criteria: (1)Pregnant or lactating women (2)Who are or may be allergic to insulin glargine, insulin detemir, Insulin Aspart or its components (3)Diabetic ketoacidosis, severe infection, severe trauma (4) Severe hepatic and renal dysfunction (5) T1DM and other special type of diabetes mellitus (DM) (6) Any other disease considered by the investigator to be likely to interfere with participation in the pilot study or evaluation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Midnight blood glucose;fasting blood glucose;blood glucose before three meals;blood glucose 2 hours after three meals;blood glucose before sleep;insulin dosage;duration achieving target; | — |
Secondary
| Measure | Time frame |
|---|---|
| hypoglycemia; | — |
Countries
China
Contacts
Public ContactWangen Li
The Second Affiliated Hospital, Guangzhou Medical University
Outcome results
None listed